HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biochemical studies on the collagen of the palmar aponeurosis affected with Dupuytren's disease.

Abstract
The palmar aponeurosis of patients affected with Dupuytren's disease was examined for collagen characteristics with regard to extractability, polymorphism, and posttranslational modifications, and the results were compared with those from normal subjects. The increased proportion of type III collagen relative to type I collagen in the affected tissue confirmed the previous findings in this disease. A slight but significant increase in a ratio of glucosylgalactosylhydroxylysine to galactosylhydroxylysine in the Dupuytren's tissue may be interpreted by the increase in the content of type III collagen. The affected tissue contained increased amounts of dihydroxylysinonorleucine as the reducible cross-link of collagen. These data support the view that Dupuytren's tissue contains collagen resembling that in granulation and embryonic tissues. Pyridinoline was shown to occur in normal and affected aponeurosis. No change in its content suggests that this cross-link is not involved in the pathogenesis of contracture in this disease.
AuthorsT Hanyu, T Tajima, T Takagi, S Sasaki, D Fujimoto, M Isemura, Z Yosizawa
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 142 Issue 4 Pg. 437-43 (Apr 1984) ISSN: 0040-8727 [Print] Japan
PMID6740656 (Publication Type: Journal Article)
Chemical References
  • Amino Acids
  • Dipeptides
  • hydroxylysine glycoside
  • 5,5'-dihydroxylysylnorleucine
  • delta-hydroxylysylnorleucine
  • Hydroxylysine
  • pyridinoline
  • Collagen
Topics
  • Amino Acids (analysis)
  • Collagen (analysis, genetics)
  • Dipeptides (analysis)
  • Dupuytren Contracture (metabolism)
  • Hand
  • Humans
  • Hydroxylysine (analogs & derivatives, analysis)
  • Male
  • Polymorphism, Genetic
  • Solubility
  • Tendons (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: